Related Experiment Video
Updated: Sep 9, 2025

06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
24.3K
Risk relationship between osteoporosis and plasma proteins
Cai Chen1, Qin Zeng2, Qianling Ye3
1Department of Education, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, Guangdong Province, China.
Medicine
|September 3, 2025
Summary
This study identifies 22 plasma proteins causally linked to osteoporosis (OP) and bone mineral density (BMD). Some proteins worsen OP, while others offer protection, serving as potential therapeutic targets for this public health issue.
Area of Science:
- Genetics and Molecular Biology
- Biochemistry
- Public Health
Background:
- Osteoporosis (OP) is a significant public health concern requiring better understanding of its mechanisms.
- Identifying effective therapeutic targets for OP is crucial for clinical management.
Purpose of the Study:
- To investigate the causal relationships between plasma proteins and bone mineral density (BMD) using Mendelian randomization.
- To identify potential therapeutic targets for osteoporosis by analyzing plasma protein associations with BMD.
Main Methods:
- Mendelian randomization analysis of 4907 plasma proteins and BMD data.
- Utilized inverse variance weighted and MR-Egger methods, with strict criteria for instrumental variables.
- Functional enrichment analysis (GO, pathway) and protein-protein interaction networks (GeneMANIA) were performed.
Main Results:
- Identified 22 plasma proteins significantly associated with osteoporosis.
- Functional enrichment revealed links to Notch signaling and Toll-like receptor signaling pathways.
- Proteins like RAB6B and UDP-glucose dehydrogenase exacerbate OP, while LBP and MANIFEST protect against it.
Conclusions:
- Established causal links between specific plasma proteins and BMD, highlighting their role in osteoporosis.
- Identified protective and detrimental plasma proteins that could serve as prognostic markers and therapeutic targets for OP.
Related Concept Videos
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Drug Distribution: Plasma Protein Binding
6.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.6K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Skeleton and Calcium Homeostasis
4.8K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.8K
Hormones and Bone Tissue
2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K

